We showed an inverse association between BPIFB4 and three-vessel CAD severity, a protective effect of LAV-BPIFB4 gene delivery in a model of MI, and a positive impact of LAV-BPIFB4 protein on human cardiomyocytes and cardiac fibroblasts. This evidence concerns the gene BPIFB4 and coronary artery disorder.